TY  - JOUR
AU  - Lopez-Pedrera, Chary
AU  - Barbarroja, Nuria
AU  - Patiño-Trives, Alejandra Mª
AU  - Collantes, Eduardo
AU  - Aguirre, Mª Angeles
AU  - Perez-Sanchez, Carlos
PY  - 2019
DO  - 10.3389/fimmu.2019.00764
UR  - http://hdl.handle.net/10668/13897
T2  - Frontiers in immunology
AB  - Antiphospholipid Syndrome (APS) is an autoimmune disorder, characterized by pregnancy morbidity and/or a hyper coagulable state involving the venous or the arterial vasculature and associated with antiphospholipid antibodies (aPL), including...
LA  - en
PB  - Frontiers Research Foundation
KW  - Antiphospholipid Syndrome
KW  - Cardiovascular disease
KW  - Genomics
KW  - MicroRNAs
KW  - Therapy
KW  - Antibodies, Antiphospholipid
KW  - Antiphospholipid Syndrome
KW  - Atherosclerosis
KW  - Biomarkers
KW  - DNA Methylation
KW  - Epigenesis, Genetic
KW  - Extracellular Traps
KW  - Gene Expression Profiling
KW  - Genetic Markers
KW  - Genetic Predisposition to Disease
KW  - Genomics
KW  - Humans
KW  - MicroRNAs
KW  - Oxidative Stress
KW  - Thrombosis
TI  - New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
TY  - research article
VL  - 10
ER  -